Abstract
Abstract
Background
Attention deficit and hyperactivity disorder (ADHD) prevalence is increasing, compliance to treatment is often poor, and additional treatment options are warranted. We aim to investigate whether individualized homeopathic treatment is effective in children with ADHD when compared to placebo or usual care alone.
Methods
Thirty-seven online sources were searched with a last update in March 2021. Studies investigating the effects of individualized homeopathy against any control in ADHD (ICD-10 category F90.0) were eligible. Data were extracted to a predefined excel sheet independently by two reviewers.
Results
Six studies were analyzed. All but one were randomized and showed low-to-moderate risk of bias; two were controlled against standard treatment and four were placebo-controlled and double-blinded. The meta-analysis revealed a significant effect size across studies of Hedges’ g = 0.542 (95% CI 0.311–0.772; z = 4,61; p < 0.001) against any control and of g = 0.605 (95% CI 0.05–1.16; z = 2.16, p = 0.03) against placebo (n = 4). The effect estimations are based on studies with an average sample size of 52 participants.
Conclusions
Individualized homeopathy showed a clinically relevant and statistically robust effect in the treatment of ADHD.
Impact
This paper summarizes the current evidence of individualized homeopathy in attention deficit and hyperactivity disorder (ADHD), and the results show a clinical improvement for patients receiving this additional treatment.
Individualized homeopathy has shown evidence of effectiveness in the treatment of ADHD in several small trials, this is the first systematic review and meta-analysis.
This data may encourage caregivers to consider co-treatment or referral to individualized homeopathy when treating childhood ADHD.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference49 articles.
1. Sayal, K., Prasad, V., Daley, D., Ford, T. & Coghill, D. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry 5, 175–186 (2018).
2. Catalá-López, F. et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS ONE 12, e0180355 (2017).
3. Efron, D. et al. Patterns of long-term adhd medication use in Australian children. Arch. Dis. Child. 105, 593–597 (2020).
4. Storebø, O. J. et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies. Cochrane Database Syst. Rev. 5, CD012069 (2018).
5. Jensen, P. S. et al. 3-Year follow-up of the NIMH MTA Study. J. Am. Acad. Child Adolesc. Psychiatry 46, 989–1002 (2007).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献